Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome.

[1]  M. Kivimäki,et al.  Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. , 2015, European journal of endocrinology.

[2]  Hong-Kyu Kim,et al.  The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation. , 2015, The Journal of clinical endocrinology and metabolism.

[3]  G. Frühbeck,et al.  Increased Cardiometabolic Risk Factors and Inflammation in Adipose Tissue in Obese Subjects Classified as Metabolically Healthy. Diabetes Care 2014;37:2813–2821 , 2014, Diabetes Care.

[4]  G. Frühbeck,et al.  Increased Cardiometabolic Risk Factors and Inflammation in Adipose Tissue in Obese Subjects Classified as Metabolically Healthy , 2014, Diabetes Care.

[5]  M. Mendez,et al.  Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population , 2014, European Journal of Nutrition.

[6]  H. Pijl,et al.  Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. , 2014, Metabolism: clinical and experimental.

[7]  S. Lai,et al.  The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study. , 2014, International journal of cardiology.

[8]  B. Zinman,et al.  Are Metabolically Healthy Overweight and Obesity Benign Conditions? , 2013, Annals of Internal Medicine.

[9]  S. Legrand-Poels,et al.  Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue , 2013, Diabetologia.

[10]  J. Qiao,et al.  Prevalence of polycystic ovary syndrome in women in China: a large community-based study. , 2013, Human reproduction.

[11]  S. Czernichow,et al.  Metabolically Healthy Obesity and Risk of Mortality , 2013, Diabetes Care.

[12]  E. Andrès,et al.  Metabolic inflammation: Connecting obesity and insulin resistance , 2013, Annals of medicine.

[13]  R. Legro.  Obesity and PCOS: Implications for Diagnosis and Treatment , 2012, Seminars in Reproductive Medicine.

[14]  E. Diamanti-Kandarakis,et al.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. , 2012, Endocrine reviews.

[15]  L. Luzi,et al.  Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals , 2010, Diabetes Care.

[16]  R. Norman,et al.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. , 2010, Human reproduction.

[17]  Cliona O'Farrelly,et al.  Are Natural Killer Cells Protecting the Metabolically Healthy Obese Patient? , 2009, Obesity.

[18]  C. Aguilar-Salinas,et al.  High adiponectin concentrations are associated with the metabolically healthy obese phenotype. , 2008, The Journal of clinical endocrinology and metabolism.

[19]  K. Reynolds,et al.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.

[20]  Fritz Schick,et al.  Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.

[21]  Bing Yuan Wang,et al.  Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases * , 2008, Journal of digestive diseases.

[22]  G. Ning,et al.  Differences in insulin resistance and pancreatic B‐cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[23]  Anna Castiglione,et al.  The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.

[24]  Ralph B D'Agostino,et al.  Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. , 2006, The Journal of clinical endocrinology and metabolism.

[25]  Remi Rabasa-Lhoret,et al.  The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  A. Karelis,et al.  Can we identify metabolically healthy but obese individuals (MHO)? , 2004, Diabetes & metabolism.

[27]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[28]  E. A. Sims,et al.  Are there persons who are obese, but metabolically healthy? , 2001, Metabolism: clinical and experimental.

[29]  Giovanni Pacini,et al.  Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. , 1998, American journal of physiology. Endocrinology and metabolism.

[30]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[31]  C. Mantzoros,et al.  Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients. , 2016, Metabolism: clinical and experimental.

[32]  R. Rabasa-Lhoret,et al.  Metabolically healthy but obese individuals: relationship with hepatic enzymes. , 2010, Metabolism: clinical and experimental.

[33]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[34]  R. Azziz,et al.  Impact of obesity on the risk for polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[35]  A. Meikle.  Prevalence and Characteristics of the Metabolic Syndrome in Women With Polycystic Ovary Syndrome , 2006 .

[36]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[37]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.